Related Experiment Videos
The use of dopaminergic receptor stimulating agent (Pribedil, ET 495) in Parkinson's disease
Advances in Biochemical Psychopharmacology
|January 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Occurrence, fate and effects of Di (2-ethylhexyl) Phthalate in wastewater treatment plants: a review.
Environmental pollution (Barking, Essex : 1987)·2014
Vaginal wet mounts on asymptomatic adolescent females; are they beneficial?
Journal of pediatric and adolescent gynecology·2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Multiple sclerosis (Houndmills, Basingstoke, England)·2008
Depression in Parkinson's disease -- a review.
Acta neurologica Scandinavica·2005
Neuroactive steroid modulation of GABAA receptors.
Advances in biochemical psychopharmacology·1995
Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.
Alimentary pharmacology & therapeutics·2026
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.
Expert opinion on drug delivery·2026
Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.
Perspectives in clinical research·2026
Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.
Current opinion in pediatrics·2026
Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.
Pharmaceuticals (Basel, Switzerland)·2026